JP2001524099A - レチノイド作動剤、拮抗剤または逆作動剤型の生物学的活性を有する三置換フェニル誘導体 - Google Patents
レチノイド作動剤、拮抗剤または逆作動剤型の生物学的活性を有する三置換フェニル誘導体Info
- Publication number
- JP2001524099A JP2001524099A JP54612398A JP54612398A JP2001524099A JP 2001524099 A JP2001524099 A JP 2001524099A JP 54612398 A JP54612398 A JP 54612398A JP 54612398 A JP54612398 A JP 54612398A JP 2001524099 A JP2001524099 A JP 2001524099A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- ethyl
- alkyl
- mmol
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/66—Polycyclic acids with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/28—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式: [式中、XはO、S、C(R2)、またはNOR*であり; R*はH、C1-6アルキル、またはフェニルであり; R1はH、炭素数1〜10の低級アルキル、F、Cl、Br、I、CF3、OR2 、SR2、OCH2OC1-6アルキル、またはCF2CF3であり; R2はそれぞれ、H、炭素数1〜10の低級アルキル、R3Si、またはCOR3 であり、R3はそれぞれ、H、炭素数1〜6の低級アルキル、またはフェニルで あり; R4は炭素数1〜6の低級アルキル、F、Cl、Br、I、CF3、CF2CF3 、NO2、N(R6)2、CN、COR3、またはN(R6)−COR3であり; mは0〜3の整数であり; Y1はフェニル、ナフチル、またはピリジル、チエニル、フリル、ピリダジニ ル、ピリミジニル、ピラジニル、チアゾリル、オキサゾリル、イミダゾリルおよ びピラゾリルから成る群から選択するヘテロアリールであり、該フェニル、ナフ チルおよびヘテロアリール基は不置換であるか、または1〜3個の基R5で置換 されており、R5は炭素数1〜10のアルキル、炭素数1〜10のフルオロ置換 アルキル、炭素数2〜10/二重結合数1〜3のアルケニル、炭素数2〜10/ 三重結合数1〜3のアルキニル、F、Cl、Br、I、NO2、CN、COOH 、COOC1-6アルキル、N3、N(R6)2、OH、OR3、SR3、COR3、また はSCOR3であり; Zは −C≡C−、 −N=N−、 −N(O)=N−、 −N=N(O)−、 −N=CR6−、 −CR6=N、 −(CR6=CR6)n−(nは0〜5の整数である)、 −CO−NR6−、 −CS−NR6−、 −NR6−CO、 −NR6−CS、 −COO−、 −OCO−、 −CSO−、 −OCS−、 −CO−CR6=CR6− であり; R6はそれぞれ、Hまたは炭素数1〜6の低級アルキルであり; Y2はフェニルもしくはナフチル基であるか、またはピリジル、チエニル、フ リル、ピリダジニル、ピリミジニル、ピラジニル、チアゾリル、オキサゾリル、 イミダゾリルおよびピラゾリルから成る群から選択するヘテロアリールであり、 該フェニルおよびヘテロアリール基は不置換であるか、または1個もしくは2個 の基R4で置換されており、あるいは Zが−(CR6=CR6)nで、nが3、4または5である場合は、Y2は該(CR6 =CR6)n基とBとの間の直接結合を表し; Y3はフェニル、ピリジル、チエニルまたはフリルであり、3個までの基R1で 置換されているか、または置換されておらず、3個までの基R4で置換されてい るか、または置換されておらず; Aは(CH2)q(qは0〜5である)、炭素数3〜6の低級分枝鎖アルキル、炭 素数3〜6のシクロアルキル、炭素数2〜6/二重結合数1または2のアルケニ ル、炭素数2〜6/三重結合数1または2のアルキニルであり; Bは水素、COOHもしくは薬学的に許容し得るその塩、COOR8、CON R9R10、−CH2OH、CH2OR11、CH2OCOR11、CHO、CH(O R12)2、CH(OR13O)、−COR7、CR7(OR12)2、CR7(OR13O)、また はSi(C1-6アルキル)3であり、R7は炭素数1〜5のアルキル、シクロアルキ ルまたはアルケニル基であり、R8は炭素数1〜10のアルキル、(トリメチルシ リル)アルキル(アルキル基の炭素数1〜10)、炭素数5〜10のシクロアル キル、フェニルまたは低級アルキルフェニルであり、R9およびR10はそれぞれ 水素、炭素数1〜10のアルキル、炭素数5〜10のシクロアルキル、フェニル 、ヒドロキシフェニルまたは低級アルキルフェニルであり、R11は低級アルキル 、フェニルまたは低級アルキルフェニルであり、R12は低級アルキルであり、R13 は炭素数2〜5の2価アルキル基である。] で示される化合物。 2.XはSである請求項1記載の化合物。 3.Zは−C≡C−、−CH=CH−、−CONH−、−COO−、−OCO −、−NHCO−、および−(CR6=CR6)n−(nは0または3)から成る群 から選択する請求項1記載の化合物。 4.A−Bは(CH2)qCOOHまたは(CH2)qCOOR8である請求項1記載 の化合物。 5.R1はOHまたはOR2である請求項1記載の化合物。 6.XはO、またはCH2であり; R1はH、炭素数1〜10の低級アルキル、OCH2OCH3、またはOR2であ り; R2はH、炭素数1〜10の低級アルキル、トリ−(C1-6アルキル)シリル、ま たはCOR3であり; R4は炭素数1〜6の低級アルキル、F、Cl、Br、I、またはCF3であり ; mは0〜3の整数であり; Y1はフェニル、ナフチル、またはピリジル、チエニル、フリル、もしくはチ アゾリルから成る群から選択するヘテロアリールであり、該フェニル、ナフチル およびヘテロアリール基は不置換であるか、または1〜3個の基R5で置換され ており、R5は炭素数1〜10のアルキル、炭素数1〜10のフルオロ置換アル キル、F、Cl、Br、I、NO2、CN、COOH、またはCOOC1-6アルキ ルであり; Zは −C≡C−、 −(CR6=CR6)n−(nは0〜5の整数である)、 −CO−NR6−、 −CS−NR6−、 −NR6−CO、 −NR6−CS、 −COO−、 −OCO− であり; Y2はフェニルもしくはナフチル基であるか、またはピリジル、チエニル、も しくはフリルから成る群から選択するヘテロアリールであり、該フェニルおよび ヘテロアリール基は不置換であるか、または1個もしくは2個の基R4で置換さ れており、あるいは Zが−(CR6=CR6)nで、nが3、4または5である場合は、Y2は該(CR6 =CR6)n基とBとの間の直接結合を表し; Y3はフェニルである請求項1記載の化合物。 7.Y2はフェニルであり、Zは−C≡C−である請求項6記載の化合物。 8.式: [式中、XはO、またはCH2であり; R1はH、OCH2OCH3、またはOR2であり; R2はH、炭素数1〜10の低級アルキル、トリ−(C1-6アルキル)シリル、ま たはCOR3であり、R3はH、または低級アルキルであり; R4はH、または炭素数1〜6の低級アルキルであり; R4 *はH、またはFであり; R5はH、F、または炭素数1〜6の低級アルキルであり; R8 *はH、炭素数1〜6の低級アルキル、または薬学的に許容し得るその塩で ある。] で示される化合物。 9.XはCH2であり、R5は4−メチルである請求項8記載の化合物。 10.R4はHである請求項9記載の化合物。 11.R1はHである請求項10記載の化合物。 12.R4 *はHであり、R8 *はH、またはエチルである請求項11記載の化合 物。 13.R1はCH3OCH2O−である請求項10記載の化合物。 14.R4 *はHであり、R8 *はH、またはエチルである請求項13記載の化合 物。 15.R1はOHである請求項10記載の化合物。 16.R4 *はHであり、R8 *はH、またはエチルである請求項15記載の化合 物。 17.R1はOCH3である請求項10記載の化合物。 18.R4 *はHであり、R8 *はH、またはエチルである請求項17記載の化合 物。 19.R1はOCH(CH3)2である請求項10記載の化合物。 20.R4 *はHであり、R8 *はH、またはエチルである請求項19記載の化合 物。 21.R4 *はFであり、R8 *はH、またはエチルである請求項19記載の化合 物。 22.XはCH2であり、R5は3−メチルである請求項8記載の化合物。 23.R4はHであり、R1はOCH(CH3)2であり、R4 *はHであり、R8 *は H、またはエチルである請求項22記載の化合物。 24.XはOであり、R5は4−メチルである請求項8記載の化合物。 25.R4はHである請求項24記載の化合物。 26.R1はCH3OCH2O−である請求項25記載の化合物。 27.R4 *はHであり、R8 *はH、またはエチルである請求項26記載の化合 物。 28.R1はOHである請求項25記載の化合物。 29.R4 *はHであり、R8 *はH、またはエチルである請求項28記載の化合 物。 30.R1はOCH3である請求項25記載の化合物。 31.R4はCH3である請求項24記載の化合物。 32.R1はOHである請求項31記載の化合物。 33.R4 *はFである請求項32記載の化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/845,019 | 1997-04-19 | ||
US08/845,019 US6037488A (en) | 1997-04-19 | 1997-04-19 | Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
PCT/US1998/007394 WO1998047854A1 (en) | 1997-04-19 | 1998-04-13 | Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007260033A Division JP2008024719A (ja) | 1997-04-19 | 2007-10-03 | レチノイド作動剤、拮抗剤または逆作動剤型の生物学的活性を有する三置換フェニル誘導体 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2001524099A true JP2001524099A (ja) | 2001-11-27 |
JP2001524099A5 JP2001524099A5 (ja) | 2006-01-05 |
JP4072208B2 JP4072208B2 (ja) | 2008-04-09 |
Family
ID=25294215
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54612398A Expired - Fee Related JP4072208B2 (ja) | 1997-04-19 | 1998-04-13 | レチノイド作動剤、拮抗剤または逆作動剤型の生物学的活性を有する三置換フェニル誘導体 |
JP2007260033A Pending JP2008024719A (ja) | 1997-04-19 | 2007-10-03 | レチノイド作動剤、拮抗剤または逆作動剤型の生物学的活性を有する三置換フェニル誘導体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007260033A Pending JP2008024719A (ja) | 1997-04-19 | 2007-10-03 | レチノイド作動剤、拮抗剤または逆作動剤型の生物学的活性を有する三置換フェニル誘導体 |
Country Status (9)
Country | Link |
---|---|
US (3) | US6037488A (ja) |
EP (1) | EP0975573B1 (ja) |
JP (2) | JP4072208B2 (ja) |
AT (1) | ATE224351T1 (ja) |
AU (1) | AU734939B2 (ja) |
CA (1) | CA2286681A1 (ja) |
DE (1) | DE69808065T2 (ja) |
ES (1) | ES2184252T3 (ja) |
WO (1) | WO1998047854A1 (ja) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6037488A (en) | 1997-04-19 | 2000-03-14 | Allergan Sales, Inc. | Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
DE60035271D1 (en) | 1999-04-28 | 2007-08-02 | Inst Med Molecular Design Inc | Pyrimidincarbonsäurederivate |
AU2001290816A1 (en) | 2000-09-13 | 2002-03-26 | Bristol-Myers Squibb Company | Retinoic acid receptor antagonists as promoters of angiogenesis |
US20020193403A1 (en) | 2001-05-03 | 2002-12-19 | Allergan Sales, Inc. | Methods of treating hyperlipidemia |
EP1260546A1 (en) * | 2001-05-21 | 2002-11-27 | Borealis Technology OY | Polyolefin multilayer pipe |
GB0117645D0 (en) | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
GB0207253D0 (en) * | 2002-03-27 | 2002-05-08 | Syngenta Participations Ag | Chemical compounds |
US6620963B1 (en) | 2002-09-19 | 2003-09-16 | Allergan, Inc. | TRICYCLO[6.2.202,7]DODECA-2(7),3,5-TRIEN-4-CARBONYLAMINO-PHENYL AND TRICYCLO[6.2.202,7]DODECA-2(7),3,5-TRIEN-4-CARBONYLAMINO-HETEROARYL AND RELATED COMPOUNDS HAVING RARα RECEPTOR SELECTIVE BIOLOGICAL ACTIVITY |
US7105566B2 (en) * | 2002-10-22 | 2006-09-12 | Allergan, Inc. | Methods of treatment during vascular procedures |
FR2848424B1 (fr) * | 2002-12-13 | 2006-06-23 | Oreal | Mascara comprenant un polymere filmogene et une phase grasse |
JP2007518719A (ja) * | 2003-12-26 | 2007-07-12 | アラーガン インコーポレイテッド | RARγレチノイド受容体アンタゴニスト活性を有する二置換カルコンオキシム |
US7476673B2 (en) * | 2003-12-30 | 2009-01-13 | Allergan, Inc. | Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors |
CN101316583A (zh) | 2005-09-30 | 2008-12-03 | 生命医药公司 | 用特异性rxr激动剂治疗癌症 |
JP2009537540A (ja) * | 2006-05-16 | 2009-10-29 | ビテ ファーマシューティカルズ, インコーポレイテッド | 化学療法および/または放射線療法の副作用を処置するためのrarアンタゴニストまたはrarインバースアゴニストの使用 |
WO2009137335A1 (en) * | 2008-05-05 | 2009-11-12 | The Scripps Research Institute | Synthesis of (+) corstistatin a and related compounds |
EP2344585B1 (en) * | 2008-10-01 | 2018-04-25 | Borealis AG | New sewage pipe material with improved properties |
CN104114171A (zh) | 2011-12-13 | 2014-10-22 | Io治疗公司 | 使用rxr激动剂的自身免疫紊乱的治疗 |
KR102149321B1 (ko) | 2015-10-31 | 2020-08-28 | 아이오 테라퓨틱스, 인크. | Rxr 아고니스트와 갑상선 호르몬의 조합을 사용한 신경계 질환의 치료 |
WO2017091762A1 (en) | 2015-11-25 | 2017-06-01 | Io Therapeutics, Inc. | Use of cyp26-resistant rar alpha selective agonists in the treatment of cancer |
KR20180121983A (ko) | 2016-03-10 | 2018-11-09 | 아이오 테라퓨틱스, 인크. | Rxr 작용제 및 갑상선 호르몬의 조합을 사용한 근육 질환의 치료 |
CN115252789A (zh) | 2016-03-10 | 2022-11-01 | Io治疗公司 | Rxr激动剂和甲状腺激素在制备用于治疗自身免疫疾病的药物中的用途 |
CA3026563C (en) | 2016-06-10 | 2023-11-28 | Io Therapeutics, Inc. | Receptor selective retinoid and rexinoid compounds and immune modulators for cancer immunotherapy |
AU2018301810A1 (en) | 2017-07-13 | 2020-01-23 | Io Therapeutics, Inc. | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy |
JP2020532537A (ja) | 2017-08-31 | 2020-11-12 | アイオー セラピューティクス インコーポレイテッド | がん免疫治療法のための免疫調節物質と併せたrar選択的アゴニスト |
US11517549B2 (en) | 2017-09-20 | 2022-12-06 | Io Therapeutics, Inc. | Treatment of disease with esters of selective RXR agonists |
US10966950B2 (en) | 2019-06-11 | 2021-04-06 | Io Therapeutics, Inc. | Use of an RXR agonist in treating HER2+ cancers |
AU2022408160A1 (en) | 2021-12-07 | 2024-06-06 | Board Of Regents, The University Of Texas System | Use of an rxr agonist and taxanes in treating her2+ cancers |
US11998521B2 (en) | 2021-12-07 | 2024-06-04 | Io Therapeutics, Inc. | Use of an RXR agonist in treating drug resistant HER2+ cancers |
Family Cites Families (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4085091A (en) * | 1976-12-16 | 1978-04-18 | E. I. Dupont De Nemours And Company | Thermally stable, rigid polyesters from thermally stable, rigid dibasic acids and aromatic dihydroxy compounds |
US4326055A (en) * | 1977-12-22 | 1982-04-20 | Hoffmann-La Roche Inc. | Stilbene derivatives |
EP0047817A3 (de) * | 1980-08-14 | 1982-05-26 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Hydrierte Naphthaline, deren Herstellung und Verwendung sowie derartige Naphthaline enthaltende Gemische |
CH651034A5 (de) | 1982-05-12 | 1985-08-30 | Hoffmann La Roche | Chroman-, thiochroman- oder 1,2,3,4-tetrahydrochinolinderivate und ihre verwendung als arzneimittel-wirkstoffe. |
DK158947C (da) * | 1982-07-06 | 1991-01-21 | Hoffmann La Roche | Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater |
US4539154A (en) * | 1983-06-15 | 1985-09-03 | Hoffmann-La Roche Inc. | Polyene compounds |
EP0130795B1 (en) * | 1983-07-05 | 1988-11-23 | Pfizer Inc. | Carboxylic acid derivatives useful for inhibiting the degradation of cartilage |
US4826984A (en) * | 1984-04-09 | 1989-05-02 | The Board Of Regents For The Oklahoma Agricultural And Mechanical College Acting For And On Behalf Of Oklahoma State University | Heteroarotinoid compounds as anticancer agents |
JPS60222445A (ja) * | 1984-04-19 | 1985-11-07 | Yoshitomi Pharmaceut Ind Ltd | フタル酸化合物 |
JPS6122046A (ja) * | 1984-07-07 | 1986-01-30 | Koichi Shiyudo | スチルベン誘導体 |
DE3580134D1 (de) * | 1984-07-07 | 1990-11-22 | Shudo Koichi Prof Dr Chem | Benzoesaeurederivate. |
LU85544A1 (fr) * | 1984-09-19 | 1986-04-03 | Cird | Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique |
DE3434942A1 (de) * | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | Tetralin-derivate, ihre herstellung und verwendung |
DE3434947A1 (de) * | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | Isoxazolcarbonsaeure-derivate, ihre herstellung und verwendung |
IL80270A0 (en) * | 1985-10-11 | 1987-01-30 | Cird | Naphthalene derivatives,their preparation and pharmaceutical compositions containing them |
DE3602473A1 (de) | 1986-01-28 | 1987-07-30 | Basf Ag | Vinylphenolderivate, ihre herstellung und verwendung |
LU86351A1 (fr) | 1986-03-12 | 1987-11-11 | Oreal | Composes benzopyrannyl et benzothiopyrannyl benzoiques,leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire |
DE3615157A1 (de) * | 1986-05-05 | 1987-11-12 | Schwabe Willmar Gmbh & Co | 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe |
ZW6587A1 (en) | 1986-05-13 | 1987-12-02 | Hoffmann La Roche | Tetrahydro naphthanline derivatives |
ZW7487A1 (en) | 1986-05-23 | 1987-12-16 | Hoffmann La Roche | Tetrahydronaphthaline and indane derivatives |
ZW10287A1 (en) | 1986-07-15 | 1988-01-13 | Hoffmann La Roche | Tetrahydronaphthaline and indane derivatives |
US4739098A (en) * | 1986-09-22 | 1988-04-19 | Allergan, Inc. | Ethynylphenyl-containing retinoic acid derivatives |
US4927947A (en) * | 1986-12-24 | 1990-05-22 | Allergan, Inc. | Ethynylheteroaromatic-acids having retinoic acid-like activity |
NZ222968A (en) | 1986-12-24 | 1990-05-28 | Allergan Inc | Ethynylheteroaromatic derivatives and medicaments |
US4923884A (en) * | 1986-12-24 | 1990-05-08 | Allergan, Inc. | Ethynylheteroaromatic-acids having retinoic acid-like activity |
DE3707060A1 (de) | 1987-03-05 | 1988-09-22 | Hoelter Heinz | Herstellung von spezialkohlen aus abfallprodukten der kohlegewinnung fuer die reduzierung von no(pfeil abwaerts)x(pfeil abwaerts), so(pfeil abwaerts)2(pfeil abwaerts)/so(pfeil abwaerts)3(pfeil abwaerts), hcl und hf in kohlegefeuerten kraftwerken oder heizanlagen, die mit einer wirbelschicht, einem wanderrost oder einer staubkohlenfeuerung ausgeruestet sind |
US5149705A (en) | 1987-03-13 | 1992-09-22 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
US5234926A (en) * | 1987-03-20 | 1993-08-10 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US5602130A (en) * | 1987-03-20 | 1997-02-11 | Allergan | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
CA1305480C (en) | 1987-03-20 | 1992-07-21 | Roshantha A.S. Chandraratna | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US5089509A (en) * | 1988-09-15 | 1992-02-18 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US5264578A (en) * | 1987-03-20 | 1993-11-23 | Allergan, Inc. | Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
US4810804A (en) * | 1987-03-26 | 1989-03-07 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid-like activity |
ZA882251B (en) | 1987-04-06 | 1989-11-29 | Riker Laboratories Inc | Substituted di-t-butylphenols |
DE3726806A1 (de) | 1987-08-12 | 1989-02-23 | Basf Ag | Arylphosphorderivate, ihre herstellung und verwendung |
ZA885192B (en) | 1987-08-19 | 1989-04-26 | Hoffmann La Roche | Pharmaceutical preparations |
CA1298309C (en) | 1987-11-06 | 1992-03-31 | Michael Klaus | Benzocycloheptene derivatives |
US5231113A (en) * | 1988-04-11 | 1993-07-27 | Allergan, Inc. | Tetralin esters of phenols or benzoic acids having retinoid like activity |
KR0139216B1 (ko) * | 1988-04-11 | 1998-05-01 | 제임스 엠. 캐내지 | 레티노이드 유사활성을 갖는 페놀 또는 벤조산의 테트랄린 에스테르 |
US4895868A (en) * | 1988-06-29 | 1990-01-23 | Allergan, Inc. | Thiochroman esters of phenols and terephthallates having retinoid-like activity |
US5015658A (en) * | 1988-06-29 | 1991-05-14 | Allergan, Inc. | Thiochroman esters of phenols and terephthallates having retinoid-like activity |
AU626881B2 (en) | 1988-07-14 | 1992-08-13 | F. Hoffmann-La Roche Ag | Benzofused heterocyclics used as pharmaceuticals |
US5217867A (en) | 1988-11-30 | 1993-06-08 | The Salk Institute For Biological Studies | Receptors: their identification, characterization, preparation and use |
WO1990007517A1 (en) | 1988-12-23 | 1990-07-12 | The Salk Institute For Biological Studies | Receptor transcription-repression activity compositions and methods |
US4992468A (en) * | 1989-07-26 | 1991-02-12 | Allergan, Inc. | Phenylethenyl compounds having retinoid-like activity |
US5068252A (en) * | 1989-07-26 | 1991-11-26 | Allergan, Inc. | Methods of using phenylethenyl compounds having retinoid-like activity |
DE3926148A1 (de) | 1989-08-08 | 1991-02-28 | Basf Ag | Diarylacetylene, ihre herstellung und verwendung |
US5183827A (en) * | 1989-09-19 | 1993-02-02 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5053523A (en) * | 1989-09-19 | 1991-10-01 | Allergan, Inc. | Ethynyl-chroman compounds |
US5162546A (en) * | 1989-09-19 | 1992-11-10 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5023341A (en) * | 1989-09-19 | 1991-06-11 | Allergan, Inc. | Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
US5045551A (en) * | 1989-09-19 | 1991-09-03 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5272156A (en) * | 1989-09-19 | 1993-12-21 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5399561A (en) * | 1989-09-19 | 1995-03-21 | Allergan, Inc. | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity |
US4980369A (en) * | 1989-09-19 | 1990-12-25 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity |
US5248777A (en) * | 1989-09-19 | 1993-09-28 | Allergan, Inc. | Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
US5264456A (en) * | 1989-12-29 | 1993-11-23 | Allergan, Inc. | Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity |
US5006550A (en) * | 1989-12-29 | 1991-04-09 | Allergan, Inc. | Chroman esters of phenols and benzoic acids having retinoid-like activity |
US5013744B1 (en) * | 1989-12-29 | 1994-09-20 | Allegran Inc | Acetylenes disubstituted with a pyridinyl group and a substituted phenyl group having retinoid like activity |
US5175185A (en) * | 1989-12-29 | 1992-12-29 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
US5202471A (en) * | 1990-02-06 | 1993-04-13 | Allergan, Inc. | Alkyl, alkoxy and thioalkoxy substituted diphenyl acetylenes having retinoid like activity |
ES2069285T3 (es) | 1990-03-20 | 1995-05-01 | Shionogi & Co | Nuevo metodo para la preparacion de derivados del acido benzoico. |
US5563292A (en) * | 1990-10-17 | 1996-10-08 | Schering Corporation | Lipoxygenase inhibitors |
DE69214632T2 (de) * | 1991-02-13 | 1997-05-28 | Allergan Inc | 7-phenylethynyl-substituierte chromane und thiochromane mit retinoid-ähnlicher biologischer aktivität |
IE920949A1 (en) * | 1991-03-26 | 1992-10-07 | Allergan Inc | Chromans and thiochromans with heteroarylethynyl¹substituents at the 7-position having retinoid-like¹biological activity |
US5134159A (en) * | 1991-03-26 | 1992-07-28 | Allergan, Inc. | 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
FR2676440B1 (fr) | 1991-05-15 | 1993-07-30 | Cird Galderma | Nouveaux composes aromatiques derives d'imine, leur procede de preparation et leur utilisation en medecine humaine et veterinaire ainsi qu'en cosmetique. |
DE69232537T2 (de) | 1991-09-17 | 2002-10-24 | Salk Inst For Biolog Studies L | Rezeptoren der steroid/thyroid superfamilie von rezeptoren |
US5326898A (en) * | 1992-02-11 | 1994-07-05 | Allergan, Inc. | Substituted phenylethenyl compounds having retinoid-like biological activity |
CA2129831A1 (en) * | 1992-02-11 | 1993-08-19 | Roshantha A. S. Chandraratna | Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
US5420145A (en) * | 1993-03-22 | 1995-05-30 | Koichi Shudo | Carboxylic acid derivative |
EP0617020A1 (en) | 1992-04-02 | 1994-09-28 | Shudo, Koichi, Prof. Dr. | Carboxylic acid derivatives having retinoic acid-like activity |
US5324840A (en) * | 1992-06-11 | 1994-06-28 | Allergan, Inc. | Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
US5466861A (en) * | 1992-11-25 | 1995-11-14 | Sri International | Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors |
US5455265A (en) * | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
US5399586A (en) * | 1993-03-11 | 1995-03-21 | Allergan, Inc. | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
EP0619116A3 (en) | 1993-04-05 | 1994-11-23 | Hoechst Japan | Use of synthetic retinoids for osteopathy. |
US5344959A (en) * | 1993-05-18 | 1994-09-06 | Allergan, Inc. | Tetrahydronaphthyl and cyclopropyl substituted 1,3-butadienes having retinoid-like activity |
US5475022A (en) * | 1993-10-18 | 1995-12-12 | Allergan, Inc. | Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
FR2713635B1 (fr) | 1993-12-15 | 1996-01-05 | Cird Galderma | Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. |
US5470999A (en) * | 1993-12-30 | 1995-11-28 | Allergan, Inc. | Cyclohexene and bicyclic aromatic substituted ethyne compounds having retinoid-like biological activity |
US5426118A (en) * | 1993-12-30 | 1995-06-20 | Allergan, Inc. | [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
US5451605A (en) * | 1993-12-30 | 1995-09-19 | Allergan, Inc. | 1,2-epoxycyclohexanyl and bicyclic aromatic substituted ethyne compounds having retinoid-like biological activity |
CA2138000A1 (en) | 1994-01-03 | 1995-07-04 | John E. Starrett, Jr. | Retinoid-like compounds |
CA2137997A1 (en) * | 1994-01-03 | 1995-07-04 | John E. Starrett, Jr. | Retinoid-like compounds |
US5498755A (en) * | 1994-08-23 | 1996-03-12 | Chandraratna; Roshantha A. | Disubstituted aryl and heteroaryl imines having retinoid-like biological activity |
IL116259A (en) | 1994-12-19 | 2000-07-16 | American Cyanamid Co | Analogs of 9-cis retinoic acid and their use |
US5498795A (en) * | 1994-12-29 | 1996-03-12 | Allergan, Inc. | Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity |
US5514825A (en) * | 1994-12-29 | 1996-05-07 | Allergan, Inc. | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
US5534641A (en) * | 1994-12-29 | 1996-07-09 | Allergan | Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity |
US5543534A (en) * | 1994-12-29 | 1996-08-06 | Allergan | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
US5618931A (en) * | 1994-12-29 | 1997-04-08 | Allergan | Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
US5489584A (en) * | 1994-12-29 | 1996-02-06 | Allergan, Inc. | Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
US5618943A (en) * | 1994-12-29 | 1997-04-08 | Allergan | Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
US5599967A (en) * | 1994-12-29 | 1997-02-04 | Allergan | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity |
US5556996A (en) * | 1994-12-29 | 1996-09-17 | Allergan | Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity |
US5648514A (en) * | 1994-12-29 | 1997-07-15 | Allergan | Substituted acetylenes having retinoid-like biological activity |
US5559248A (en) * | 1995-04-05 | 1996-09-24 | Bristol-Myers Squibb Co. | Retinoid-like heterocycles |
US5616712A (en) * | 1995-05-16 | 1997-04-01 | Allergan | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity |
US5675033A (en) * | 1995-06-06 | 1997-10-07 | Allergan | 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
US5663357A (en) * | 1995-11-22 | 1997-09-02 | Allergan | Substituted heteroarylamides having retinoid-like biological activity |
US6037488A (en) | 1997-04-19 | 2000-03-14 | Allergan Sales, Inc. | Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
-
1997
- 1997-04-19 US US08/845,019 patent/US6037488A/en not_active Expired - Fee Related
-
1998
- 1998-04-13 WO PCT/US1998/007394 patent/WO1998047854A1/en active IP Right Grant
- 1998-04-13 CA CA002286681A patent/CA2286681A1/en not_active Abandoned
- 1998-04-13 EP EP98918157A patent/EP0975573B1/en not_active Expired - Lifetime
- 1998-04-13 ES ES98918157T patent/ES2184252T3/es not_active Expired - Lifetime
- 1998-04-13 AT AT98918157T patent/ATE224351T1/de not_active IP Right Cessation
- 1998-04-13 AU AU71132/98A patent/AU734939B2/en not_active Ceased
- 1998-04-13 JP JP54612398A patent/JP4072208B2/ja not_active Expired - Fee Related
- 1998-04-13 DE DE69808065T patent/DE69808065T2/de not_active Expired - Fee Related
-
1999
- 1999-09-16 US US09/398,564 patent/US6225494B1/en not_active Expired - Fee Related
-
2000
- 2000-01-25 US US09/490,658 patent/US6235923B1/en not_active Expired - Fee Related
-
2007
- 2007-10-03 JP JP2007260033A patent/JP2008024719A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2008024719A (ja) | 2008-02-07 |
US6037488A (en) | 2000-03-14 |
AU7113298A (en) | 1998-11-13 |
WO1998047854A1 (en) | 1998-10-29 |
US6225494B1 (en) | 2001-05-01 |
US6235923B1 (en) | 2001-05-22 |
DE69808065T2 (de) | 2003-05-22 |
EP0975573B1 (en) | 2002-09-18 |
JP4072208B2 (ja) | 2008-04-09 |
ATE224351T1 (de) | 2002-10-15 |
EP0975573A1 (en) | 2000-02-02 |
ES2184252T3 (es) | 2003-04-01 |
AU734939B2 (en) | 2001-06-28 |
CA2286681A1 (en) | 1998-10-29 |
DE69808065D1 (de) | 2002-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001524099A (ja) | レチノイド作動剤、拮抗剤または逆作動剤型の生物学的活性を有する三置換フェニル誘導体 | |
US5919970A (en) | Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity | |
JP4052668B2 (ja) | レチノイド様生物学的活性を有する2,4−ペンタジエン酸誘導体 | |
JP2001505914A (ja) | レチノイド拮抗剤またはレチノイド逆作動剤型の生物学的活性を有する、アリールまたはヘテロアリール置換3,4−ジヒドロアントラセン、並びにアリールまたはヘテロアリール置換ベンゾ[1,2−g]−クロマ−3−エン、ベンゾ[1,2−g]−チオクロマ−3−エンおよびベンゾ[1,2−g]−1,2−ジヒドロキノリン誘導体 | |
JP2001504458A (ja) | レチノイド受容体に対し作動剤、拮抗剤または逆作動剤型活性を有するn―アリール置換テトラヒドロキノリンリガンド | |
AU720975B2 (en) | Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity | |
JPH07508725A (ja) | レチノイド様活性を有するビニルアレーン | |
CA2165374A1 (en) | Restricted 9-cis-retenoids | |
US20030166932A1 (en) | Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity | |
JP2002526516A (ja) | レチノイドx(rxr)受容体に選択的な活性を有する2,4−ペンタジエン酸誘導体 | |
US20040097733A1 (en) | Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity | |
JPH07223997A (ja) | ビアリールホスホリパーゼ▲a2▼阻害剤 | |
WO2001070662A2 (en) | 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors | |
US6465647B1 (en) | Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity | |
US6388105B1 (en) | Benzofuran, indole or benzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors | |
US6465646B1 (en) | 1-alkoxy and 1-acyloxy substituted cyclohex-1-ene compounds and sulfur and 1-alkoxycarbonyl analogs having retinoid-like biological activity | |
US6620963B1 (en) | TRICYCLO[6.2.202,7]DODECA-2(7),3,5-TRIEN-4-CARBONYLAMINO-PHENYL AND TRICYCLO[6.2.202,7]DODECA-2(7),3,5-TRIEN-4-CARBONYLAMINO-HETEROARYL AND RELATED COMPOUNDS HAVING RARα RECEPTOR SELECTIVE BIOLOGICAL ACTIVITY | |
MXPA99005104A (en) | Aryl or heteroar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050407 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050713 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070403 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070703 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070820 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071003 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080108 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080121 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110125 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |